Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Tucci

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 17, 2007
Pyrrolidines as potent functional agonists of the human melanocortin-4 receptorJoe A Tran, Caroline W Chen, Wanlong Jiang, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
A convenient one-pot synthesis of asymmetric 1,3,5-triazine-2,4,6-triones and its application towards a novel class of gonadotropin-releasing hormone receptor antagonistsZhiqiang Guo, Dongpei Wu, Yun-Fei Zhu, et al.
The Journal of Organic Chemistry|October 22, 2005
Practical asymmetric synthesis of alpha-branched 2-piperazinylbenzylamines by 1,2-additions of organometallic reagents to N-tert-butanesulfinyl iminesWanlong Jiang, Chen Chen, Dragan Marinkovic, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|January 29, 2008
Studies on the structure-activity relationship of the basic amine of phenylpiperazines as melanocortin-4 receptor antagonistsJoe A Tran, Melissa Arellano, Beth A Fleck, et al.
Oncotarget|May 29, 2018
Limited fibrosis accompanies triple-negative breast cancer metastasis in multiple model systems and is not a preventive targetDanielle Brooks, Alexandra Zimmer, Lalage Wakefield, et al.
Hepatology Communications|November 23, 2023
Lysophosphatidic acid receptor 1 antagonist (EPGN2154) causes regression of NASH in preclinical NASH modelsJashdeep Bhattacharjee, Graham Beaton, Satheesh B Ravula, et al.
Journal of the National Cancer Institute|January 5, 1994
Dietary beta carotene and lung cancer risk in U.S. nonsmokersS T Mayne, D T Janerich, P Greenwald, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Synthesis and structure-activity relationships of 1-arylmethyl-3-(1-methyl-2-amino)ethyl-5-aryl-6-methyluracils as antagonists of the human GnRH ReceptorFabio C Tucci, Yun-Fei Zhu, Zhiqiang Guo, et al.
Journal of Medicinal Chemistry|December 24, 2004
4-{(2R)-[3-Aminopropionylamido]-3-(2,4-dichlorophenyl)propionyl}-1-{2-[(2-thienyl)ethylaminomethyl]phenyl}piperazine as a potent and selective melanocortin-4 receptor antagonist--design, synthesis, and characterizationChen Chen, Joseph Pontillo, Beth A Fleck, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2005
Structure-activity relationship studies on a series of cyclohexylpiperazines bearing a phanylacetamide as ligands of the human melanocortin-4 receptorJoseph Pontillo, Joe A Tran, Nicole S White, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry Letters|July 17, 2007
Pyrrolidines as potent functional agonists of the human melanocortin-4 receptorJoe A Tran, Caroline W Chen, Wanlong Jiang, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
A convenient one-pot synthesis of asymmetric 1,3,5-triazine-2,4,6-triones and its application towards a novel class of gonadotropin-releasing hormone receptor antagonistsZhiqiang Guo, Dongpei Wu, Yun-Fei Zhu, et al.
The Journal of Organic Chemistry|October 22, 2005
Practical asymmetric synthesis of alpha-branched 2-piperazinylbenzylamines by 1,2-additions of organometallic reagents to N-tert-butanesulfinyl iminesWanlong Jiang, Chen Chen, Dragan Marinkovic, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|January 29, 2008
Studies on the structure-activity relationship of the basic amine of phenylpiperazines as melanocortin-4 receptor antagonistsJoe A Tran, Melissa Arellano, Beth A Fleck, et al.
Oncotarget|May 29, 2018
Limited fibrosis accompanies triple-negative breast cancer metastasis in multiple model systems and is not a preventive targetDanielle Brooks, Alexandra Zimmer, Lalage Wakefield, et al.
Hepatology Communications|November 23, 2023
Lysophosphatidic acid receptor 1 antagonist (EPGN2154) causes regression of NASH in preclinical NASH modelsJashdeep Bhattacharjee, Graham Beaton, Satheesh B Ravula, et al.
Journal of the National Cancer Institute|January 5, 1994
Dietary beta carotene and lung cancer risk in U.S. nonsmokersS T Mayne, D T Janerich, P Greenwald, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Synthesis and structure-activity relationships of 1-arylmethyl-3-(1-methyl-2-amino)ethyl-5-aryl-6-methyluracils as antagonists of the human GnRH ReceptorFabio C Tucci, Yun-Fei Zhu, Zhiqiang Guo, et al.
Journal of Medicinal Chemistry|December 24, 2004
4-{(2R)-[3-Aminopropionylamido]-3-(2,4-dichlorophenyl)propionyl}-1-{2-[(2-thienyl)ethylaminomethyl]phenyl}piperazine as a potent and selective melanocortin-4 receptor antagonist--design, synthesis, and characterizationChen Chen, Joseph Pontillo, Beth A Fleck, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2005
Structure-activity relationship studies on a series of cyclohexylpiperazines bearing a phanylacetamide as ligands of the human melanocortin-4 receptorJoseph Pontillo, Joe A Tran, Nicole S White, et al.
Pageof 9